Schroder Investment Management Group Has $7.83 Million Stock Position in Humana Inc. (NYSE:HUM)

Schroder Investment Management Group lessened its position in shares of Humana Inc. (NYSE:HUM) by 16.5% during the 4th quarter, HoldingsChannel reports. The fund owned 30,882 shares of the insurance provider’s stock after selling 6,094 shares during the quarter. Schroder Investment Management Group’s holdings in Humana were worth $7,825,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. boosted its stake in Humana by 15.8% in the fourth quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider’s stock valued at $3,254,899,000 after acquiring an additional 1,751,857 shares during the last quarter. Norges Bank bought a new position in shares of Humana in the 4th quarter worth $416,202,000. Pzena Investment Management LLC grew its stake in shares of Humana by 44.0% during the fourth quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider’s stock worth $915,736,000 after purchasing an additional 1,103,132 shares during the period. Boston Partners increased its holdings in Humana by 435.8% in the fourth quarter. Boston Partners now owns 1,098,702 shares of the insurance provider’s stock valued at $279,236,000 after purchasing an additional 893,637 shares during the last quarter. Finally, Artisan Partners Limited Partnership lifted its stake in Humana by 83.4% in the fourth quarter. Artisan Partners Limited Partnership now owns 673,715 shares of the insurance provider’s stock valued at $170,928,000 after buying an additional 306,433 shares during the period. Institutional investors own 92.38% of the company’s stock.

Analyst Ratings Changes

HUM has been the subject of a number of recent analyst reports. Barclays upped their price target on Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a research note on Thursday, February 13th. Cantor Fitzgerald reissued a “neutral” rating and issued a $290.00 price target on shares of Humana in a report on Wednesday, February 12th. JPMorgan Chase & Co. dropped their price objective on Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a research note on Tuesday, February 18th. Royal Bank of Canada reissued an “outperform” rating and issued a $283.00 target price on shares of Humana in a research note on Wednesday, February 12th. Finally, Truist Financial increased their price target on Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a report on Monday, January 6th. Eighteen investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $280.17.

Humana Trading Down 4.6 %

Humana stock opened at $253.37 on Friday. The company has a market cap of $30.58 billion, a price-to-earnings ratio of 25.46, a P/E/G ratio of 2.05 and a beta of 0.62. The firm has a 50-day moving average of $267.58 and a 200-day moving average of $272.13. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. Humana Inc. has a one year low of $213.31 and a one year high of $406.46.

Humana (NYSE:HUM) last posted its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, equities analysts expect that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.40%. The ex-dividend date is Friday, March 28th. Humana’s dividend payout ratio is currently 35.58%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.